HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 436 filers reported holding HORIZON THERAPEUTICS PUB L in Q3 2020. The put-call ratio across all filers is 1.02 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $21,573 | -29.2% | 186,470 | -37.1% | 0.03% | -20.5% |
| Q2 2023 | $30,471 | -9.2% | 296,270 | -3.7% | 0.04% | -13.3% |
| Q1 2023 | $33,570 | -8.0% | 307,588 | -4.1% | 0.04% | -10.0% |
| Q4 2022 | $36,493 | -99.8% | 320,679 | +33.2% | 0.05% | +127.3% |
| Q3 2022 | $14,899,000 | -35.5% | 240,732 | -16.8% | 0.02% | -26.7% |
| Q2 2022 | $23,082,000 | -30.8% | 289,394 | -8.7% | 0.03% | -16.7% |
| Q1 2022 | $33,361,000 | +15.6% | 317,093 | +18.4% | 0.04% | +24.1% |
| Q4 2021 | $28,866,000 | -2.1% | 267,869 | -0.5% | 0.03% | -6.5% |
| Q3 2021 | $29,487,000 | +19.6% | 269,187 | +2.2% | 0.03% | +19.2% |
| Q2 2021 | $24,658,000 | +2.8% | 263,332 | +1.0% | 0.03% | -3.7% |
| Q1 2021 | $23,996,000 | +15.5% | 260,709 | -8.2% | 0.03% | +17.4% |
| Q4 2020 | $20,771,000 | -15.4% | 283,956 | -10.2% | 0.02% | -23.3% |
| Q3 2020 | $24,550,000 | +35.7% | 316,046 | -2.9% | 0.03% | +30.4% |
| Q2 2020 | $18,093,000 | +58.3% | 325,536 | -15.7% | 0.02% | +35.3% |
| Q1 2020 | $11,433,000 | -25.9% | 385,982 | -9.5% | 0.02% | -5.6% |
| Q4 2019 | $15,433,000 | +24.8% | 426,319 | -6.2% | 0.02% | +12.5% |
| Q3 2019 | $12,369,000 | +22.4% | 454,258 | +8.2% | 0.02% | +23.1% |
| Q2 2019 | $10,102,000 | – | 419,861 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 544,835 | $57,322,000 | 30.98% |
| Paulson & Co. | 5,614,000 | $590,649,000 | 18.18% |
| Avoro Capital Advisors LLC | 6,500,000 | $683,865,000 | 12.48% |
| 1492 Capital Management LLC | 121,840 | $12,819,000 | 6.80% |
| Iron Triangle Partners LP | 503,744 | $52,999,000 | 6.30% |
| Tri Locum Partners LP | 132,332 | $13,923,000 | 5.44% |
| HealthCor Management, L.P. | 710,110 | $74,711,000 | 4.98% |
| Eversept Partners, LP | 609,939 | $64,171,682 | 4.93% |
| Bain Capital Public Equity Management II, LLC | 1,286,371 | $135,339,000 | 4.33% |
| PFM Health Sciences, LP | 1,091,840 | $114,872,000 | 4.30% |